Related Experiment Video
Updated: Aug 4, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Intralipid as treatment for recurrent unexplained abortion?
1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|December 1, 1994
Summary
Intralipid, an inexpensive lipid emulsion, shows promise as an effective treatment for recurrent pregnancy loss. Studies suggest it may prevent miscarriages and warrants further investigation in large clinical trials.
Area of Science:
- Immunology
- Reproductive Medicine
- Pharmacology
Background:
- Recurrent pregnancy loss (RPL) necessitates safe, effective, and affordable treatments.
- Current options like partner leukocyte immunotherapy and IVIG are effective but costly.
- Psychotherapy's effectiveness in RPL is uncertain and treatment forms can be expensive.
Purpose of the Study:
- To investigate Intralipid as a potential alternative treatment for RPL.
- To evaluate the efficacy of Intralipid in preventing spontaneous abortions.
- To assess the ethical acceptability of Intralipid treatment in women.
Main Methods:
- Reviewed a published double-blind randomized controlled trial comparing Intralipid to trophoblast membrane vesicles.
- Tested predictions from human data in a DBA/2-mated CBA/J mouse model of recurrent spontaneous abortion.
Main Results:
- Human trial data suggests Intralipid may be an effective anti-abortion treatment, even in small doses.
- Intralipid demonstrated high efficacy in preventing abortions in mice, with prolonged protection.
- Intralipid's effects on the reticuloendothelial system may explain its efficacy.
Conclusions:
- Intralipid shows potential as an effective treatment for human recurrent miscarriages.
- Intralipid injections are considered ethically acceptable for women of childbearing potential.
- Further large-scale, multicenter randomized controlled trials are needed to compare Intralipid with existing immunotherapies.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...